2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.
Open Access
- 1 March 1983
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 71 (3) , 420-428
- https://doi.org/10.1172/jci110786
Abstract
2-Methylthio-ADP and its radioactive analogue [beta-32P]2-methylthio-ADP were synthesized and used to investigate platelet receptors for ADP. 2-Methylthio-ADP induced platelet aggregation and shape change, and inhibited cyclic AMP accumulation in platelets exposed to prostaglandin E1. Compared with ADP, 2-methylthio-ADP was 3-5 times as active as an aggregating agent and 150-200 times as active as an inhibitor of cyclic AMP accumulation. Binding of [beta-32P]2-methylthio-ADP to platelets was measured after centrifuging them through silicone oil to separate platelets from their suspension medium. Binding was reversible, saturable, and specific, with between 400 and 1,200 sites/cell in different platelet preparations. There was no evidence for a second class of binding sites with different affinity. The second order association rate constant was approximately 3.5 X 10(6) M-1 S-1, and the first order dissociation rate was 0.024 s-1, both measured at 23 degrees C. The dissociation equilibrium constant (approximately 15 nM) was about three times higher than the concentration giving half-maximal inhibition of prostaglandin E1-stimulated cyclic AMP accumulation in platelet-rich plasma. Binding was inhibited by ADP (Ki = 3.5 microM), ATP (7 microM), 2-azido-ADP (0.12 microM), inosine diphosphate (IDP, 150 microM), guanosine diphosphate (GDP, 350 microM), and AMP (800 microM). Binding of 2-methylthio-ADP was also blocked by the non-cell-penetrating thiol reagent, p-mercuribenzene sulphonate, a reagent that blocks the inhibition of adenylate cyclase by ADP, but which does not block the ability of ADP to induce aggregation or platelet shape change. The amount of 2-methylthio-ADP bound at saturation was independent of pH in the range 6-8, but the affinity was reduced at pH 6 compared with pH 6.5-8.0. The dissociation constant was not temperature dependent in the range 32 degrees -40 degrees C, whereas the rate of dissociation of 2-methylthio-ADP from platelets after the addition of an excess of ADP approximately doubled over this range. The activation energy for dissociation was approximately 15 kcal/mol. Our results support the conclusion that platelets have a receptor for ADP, which inhibits cyclic AMP accumulation, and which has a sulphydryl group in the binding pocket.This publication has 12 references indexed in Scilit:
- PARALLEL OBSERVATION OF THE OCCUPANCY OF THE ALPHA-2-ADRENERGIC RECEPTOR IN INTACT PLATELETS AND ITS ABILITY TO INHIBIT THE ADENYLATE-CYCLASE1982
- BIDIRECTIONAL COLLISION COUPLING IN THE REGULATION OF THE ADENYLATE-CYCLASE - THE ALLOZYME HYPOTHESIS FOR RECEPTOR FUNCTION1982
- Use of [methyl-3H]yohimbine as a radioligand for alpha-2 adrenoreceptors on intact platelets. Comparison with dihydroergocryptineThrombosis Research, 1981
- INHIBITION BY ADP OF PROSTAGLANDIN INDUCED ACCUMULATION OF CYCLIC-AMP IN INTACT HUMAN-PLATELETS1981
- ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclaseNature, 1979
- Metabolism and Function of Human Platelets Washed by Albumin Density Gradient SeparationBritish Journal of Haematology, 1977
- Binding of adenosine diphosphate to intact human platelets.The Journal of Physiology, 1975
- The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation.1975
- Enzyme Activities on the Platelet Surface in Relation to the Action of Adenosine DiphosphatePublished by Wiley ,1975
- Analogues of adenosine 5'-diphosphate-new platelet aggregators. Influence of purine ring and and phosphate chain substitutions on the platelet-aggregating potency of adenosine 5'-diphosphate.1972